EWTX

39.9402.99%
AJ

Alan J. Russell

Co-Founder, Chief Scientific Officer & Director

Dr. Alan J. Russell, Ph.D. is a Co-Founder of Edgewise Therapeutics, Inc. in 2017 and has been its Chief Scientific Officer since June 2017 and Director since August 2017. He co-founded Edgewise Therapeutics, Inc. in 2017. Previously, Dr. Russell was Vice President and Head of the Muscle Metabolism Discovery Performance Unit from September 2014 to June 2017 and Director and Head of Biology of the Muscle Metabolism Discovery Performance Unit from March 2010 to September 2014 at GlaxoSmithKline plc, a multinational pharmaceutical company. Prior to joining GlaxoSmithKline, Dr. Russell was Associate Director of Muscle Biology and Therapeutics from February 2002 to February 2010 at Cytokinetics, Inc., a biopharmaceutical company developing treatments for diseases of impaired muscle function. He has been Adjunct Professor in the Department of Integrative Physiology at the University of Colorado Boulder since November 2017. Dr. Russell received a B.Pharm. in pharmacy and pharmacology and a Ph.D. in cell biology and gene therapy from the University of Bath and was Postdoctoral Fellow at the Stanford University School of Medicine.

Positions